Antimicrobial use among paediatric inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program, 2017/2018ANTIMICROBIAL RESISTANCE AND INFECTION CONTROLIF4.42023-04-182OAAI
Antimicrobial use in Canadian acute-care hospitals: Findings from three national point-prevalence surveys between 2002 and 2017INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32022-03-074OAAI
Effectiveness of an outbreak dose of mumps-containing vaccine in two First Nations communities in Northern Ontario, CanadaHUMAN VACCINES & IMMUNOTHERAPEUTICSIF3.52021-07-222OAAI
Central-line-Associated Bloodstream Infections Among Adult Intensive Care Unit Patients in Canadian Hospitals, 2011-2018INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32020-11-020OA
Variability in Antimicrobial Use Among Hospitals Participating in the Canadian Nosocomial Infection Surveillance ProgramINFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32020-11-020OA
Prevalence ofCandida aurisin Canadian acute care hospitals among at-risk patients, 2018ANTIMICROBIAL RESISTANCE AND INFECTION CONTROLIF4.42020-06-109OAAI
A comparative exposure assessment of foodborne, animal contact and waterborne transmission routes of Salmonella in CanadaFOOD CONTROLIF6.32020-03-0121PREAI
Trends in health care-associated infections in acute care hospitals in Canada: an analysis of repeated point-prevalence surveysCANADIAN MEDICAL ASSOCIATION JOURNALIF11.32019-09-0830OAAI
Factors Associated With 30-Day Mortality Rate in Respiratory Infections Caused by Streptococcus pneumoniaeCLINICAL INFECTIOUS DISEASESIF7.32017-11-115OAAI
Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs免疫功能低下人群中的侵袭性肺炎球菌疾病: 对疫苗接种计划的影响CLINICAL INFECTIOUS DISEASESIF7.32015-09-09106OAAI
Previous Antibiotic Exposure and Antimicrobial Resistance in Invasive Pneumococcal Disease: Results From Prospective Surveillance侵袭性肺炎球菌疾病的抗生素暴露和耐药性: 前瞻性监测结果CLINICAL INFECTIOUS DISEASESIF7.32014-06-2749OAAI